These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 17224477

  • 1. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S.
    Circulation; 2007 Jan 23; 115(3):310-8. PubMed ID: 17224477
    [Abstract] [Full Text] [Related]

  • 2. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs.
    Laurent G, Leong-Poi H, Mangat I, Moe GW, Hu X, So PP, Tarulli E, Ramadeen A, Rossman EI, Hennan JK, Dorian P.
    Circ Arrhythm Electrophysiol; 2009 Apr 23; 2(2):171-8. PubMed ID: 19808462
    [Abstract] [Full Text] [Related]

  • 3. Rotigaptide (ZP123) improves atrial conduction slowing in chronic volume overload-induced dilated atria.
    Haugan K, Miyamoto T, Takeishi Y, Kubota I, Nakayama J, Shimojo H, Hirose M.
    Basic Clin Pharmacol Toxicol; 2006 Jul 23; 99(1):71-9. PubMed ID: 16867174
    [Abstract] [Full Text] [Related]

  • 4. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI, Liu K, Morgan GA, Swillo RE, Krueger JA, Gardell SJ, Butera J, Gruver M, Kantrowitz J, Feldman HS, Petersen JS, Haugan K, Hennan JK.
    J Pharmacol Exp Ther; 2009 Jun 23; 329(3):1127-33. PubMed ID: 19252062
    [Abstract] [Full Text] [Related]

  • 5. Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation.
    Guerra JM, Everett TH, Lee KW, Wilson E, Olgin JE.
    Circulation; 2006 Jul 11; 114(2):110-8. PubMed ID: 16818812
    [Abstract] [Full Text] [Related]

  • 6. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.
    Sakabe M, Shiroshita-Takeshita A, Maguy A, Dumesnil C, Nigam A, Leung TK, Nattel S.
    Circulation; 2007 Nov 06; 116(19):2101-9. PubMed ID: 17967774
    [Abstract] [Full Text] [Related]

  • 7. Rate-dependence of atrial tachycardia effects on atrial refractoriness and atrial fibrillation maintenance.
    Shiroshita-Takeshita A, Mitamura H, Ogawa S, Nattel S.
    Cardiovasc Res; 2009 Jan 01; 81(1):90-7. PubMed ID: 18801748
    [Abstract] [Full Text] [Related]

  • 8. Rotigaptide (ZP123) reverts established atrial conduction velocity slowing.
    Haugan K, Kjølbye AL, Hennan JK, Petersen JS.
    Cell Commun Adhes; 2005 Jan 01; 12(5-6):271-8. PubMed ID: 16531322
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias.
    Kjølbye AL, Haugan K, Hennan JK, Petersen JS.
    Basic Clin Pharmacol Toxicol; 2007 Oct 01; 101(4):215-30. PubMed ID: 17845503
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
    Burstein B, Comtois P, Michael G, Nishida K, Villeneuve L, Yeh YH, Nattel S.
    Circ Res; 2009 Dec 04; 105(12):1213-22. PubMed ID: 19875729
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy.
    Eloff BC, Gilat E, Wan X, Rosenbaum DS.
    Circulation; 2003 Dec 23; 108(25):3157-63. PubMed ID: 14656916
    [Abstract] [Full Text] [Related]

  • 13. Treatment with the gap junction modifier rotigaptide (ZP123) reduces infarct size in rats with chronic myocardial infarction.
    Haugan K, Marcussen N, Kjølbye AL, Nielsen MS, Hennan JK, Petersen JS.
    J Cardiovasc Pharmacol; 2006 Feb 23; 47(2):236-42. PubMed ID: 16495761
    [Abstract] [Full Text] [Related]

  • 14. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K, Kobayashi T, Kimura M, Owada S, Sasaki S, Iwasa A, Furukawa K, Motomura S, Okumura K.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):148-53. PubMed ID: 16556442
    [Abstract] [Full Text] [Related]

  • 15. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
    Shiroshita-Takeshita A, Brundel BJ, Burstein B, Leung TK, Mitamura H, Ogawa S, Nattel S.
    Cardiovasc Res; 2007 Apr 01; 74(1):75-84. PubMed ID: 17270161
    [Abstract] [Full Text] [Related]

  • 16. Atrial ischemia promotes atrial fibrillation in dogs.
    Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S.
    Circulation; 2003 Apr 15; 107(14):1930-6. PubMed ID: 12668526
    [Abstract] [Full Text] [Related]

  • 17. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans.
    Kjølbye AL, Dikshteyn M, Eloff BC, Deschênes I, Rosenbaum DS.
    Am J Physiol Heart Circ Physiol; 2008 Jan 15; 294(1):H41-9. PubMed ID: 17982010
    [Abstract] [Full Text] [Related]

  • 18. Atrial fibrillation-associated remodeling does not promote atrial thrombus formation in canine models.
    Nishida K, Chiba K, Iwasaki YK, Katsouras G, Shi YF, Blostein MD, Khairy P, Guerra PG, Dubuc M, Tardif JC, Tanguay JF, Nattel S.
    Circ Arrhythm Electrophysiol; 2012 Dec 15; 5(6):1168-75. PubMed ID: 23095228
    [Abstract] [Full Text] [Related]

  • 19. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.
    Yang SS, Han W, Zhou HY, Dong G, Wang BC, Huo H, Wei N, Cao Y, Zhou G, Xiu CH, Li WM.
    Chin Med J (Engl); 2008 Jan 05; 121(1):38-42. PubMed ID: 18208664
    [Abstract] [Full Text] [Related]

  • 20. The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure.
    Wiegerinck RF, de Bakker JM, Opthof T, de Jonge N, Kirkels H, Wilms-Schopman FJ, Coronel R.
    Basic Res Cardiol; 2009 May 05; 104(3):321-32. PubMed ID: 19139945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.